DARPA Backs Battelle and Aprecia to Accelerate Pharmaceutical 3D Printing

DARPA has partnered with Battelle and Aprecia to advance pharmaceutical 3D printing through the EQUIP-A-Pharma program. The collaboration aims to streamline pharmaceutical supply chains by producing active ingredients and medications at the same site. The project will focus on creating agile manufacturing sites for drugs like levetiracetam and linezolid. The initiative seeks to enhance the commercial appeal of pharmaceutical 3D printing and attract investment. This effort could lead to the development of new 3D printed drugs in the coming years.